Natural compound anacardic acid has been shown to bind and inhibit the first enzyme in the SUMOylation pathway. Stimulation of splenocytes with LPS resulted in reduced production of inflammatory mediators. AA treatment significantly reduced clinical paralysis and pathological CNS inflammation in experimental allergic encephalomyelitis (EAE), an animal model of multiple sclerosis.

